Every Form 4 that Paysign, Inc. (PAYS) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow PAYS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PAYS filings page.
Paysign, Inc. CEO, director and 10% owner Mark Newcomer sold 50,000 shares of common stock on October 9, 2026, at a weighted average price of $15.3379 per share under a Rule 10b5-1 trading plan adopted September 12, 2025. After the sale, he directly held 9,113,002 shares. The shares were sold in multiple transactions at prices ranging from $15.3301 to $15.3410.
Paysign, Inc. (PAYS) director and EVP, Operations Joan M. Herman reported selling a total of 59,904 shares of common stock in open-market transactions under a Rule 10b5-1 trading plan. On September 15, 2026, 21,004 shares were sold at a weighted average price of $12.3819, and on September 16, 2026, 38,900 shares were sold at a weighted average price of $11.7437, across price ranges disclosed in the footnotes.
Paysign, Inc. (PAYS) reported that Chief Innovation Officer Michael C. Ngo, through Gamma Innovation LLC, sold a total of 150,000 shares of common stock in open-market transactions on September 8–9, 2026, at weighted average prices of $12.8494 and $12.74 per share, respectively. These are indirect sales by Gamma Innovation LLC, which Ngo solely owns, while he continues to hold 461,336 Paysign shares directly as of September 8, 2026. No Rule 10b5-1 trading plan is reported for these transactions.
Paysign, Inc. (PAYS) reported that Chief Innovation Officer Michael C. Ngo had several equity-related transactions in the company’s common stock.
On March 19, 2025, 2,500,000 shares of restricted stock were issued indirectly via Gamma Innovation LLC as consideration under an Asset Purchase Agreement for substantially all of Gamma’s assets, vesting 1/5 on March 31, 2025 and annually thereafter. On the same date, Ngo received a direct grant of 500,000 restricted shares, vesting 1/5 on March 31, 2026 and annually thereafter, subject to continued service. On March 31, 2026, 38,664 shares were withheld by Paysign at $5.90 per share to satisfy tax withholding obligations on vested restricted stock.
Paysign, Inc. officer Turner Matthew Baker reported equity compensation and related tax transactions in Common Stock. On November 13, 2025, he received a grant of 233,333 shares of performance-based restricted stock, tied to an earnings target and vesting 1/3 on each of May 22, 2026, May 26, 2027, and May 24, 2028, subject to continued service. On February 3, 2026, he sold 15,057 shares at $4.16 per share, and on May 22, 2026, 50,681 shares at $6.72 per share were delivered or withheld, in both cases to satisfy tax withholding obligations on vesting restricted stock. No Rule 10b5-1 plan is reported.
Paysign, Inc. (PAYS) reported that Chief Technology Officer Bradley Kramer Cunningham disposed of common stock in several transactions. On May 29 and June 1, 2026, he sold a total of 13,000 shares of common stock at prices around $7.30–$7.80 per share, including sales executed in multiple trades at a weighted average price. On May 18, June 30, and July 31, 2026, a total of 46,378 shares of common stock were withheld by the company to satisfy tax withholding obligations related to the vesting of restricted stock and performance-based restricted stock.
Paysign, Inc. Chief Financial Officer Jeffery Bradford Baker reported selling 35,000 shares of common stock on August 12, 2026 in an open-market or private transaction. The shares were sold at a weighted average price of $12.6182 per share, with individual trade prices ranging from $12.54 to $12.72. Following this transaction, Baker directly owns 542,171 shares of Paysign common stock.
Paysign, Inc. CEO and 10% owner Mark Newcomer reported selling 150,000 shares of Common Stock on August 6, 2026 at a weighted average price of $11.8757 per share, in multiple trades between $11.2444 and $12.4641. The sale was effected under a pre-arranged Rule 10b5-1 trading plan adopted on September 12, 2025, and Newcomer continues to hold 9,163,002 shares directly after the transaction.
Paysign, Inc. director Dennis L. Triplett exercised a stock grant on August 4, 2026, converting 20,000 shares from a derivative “Stock Grant” into 20,000 shares of common stock at $0.0000 per share. The shares relate to a grant received August 4, 2025 that vested August 4, 2026. After this transaction, he directly holds 290,000 shares of Paysign common stock. These transactions were not marked as made pursuant to a Rule 10b5-1 trading plan.
Paysign, Inc. director Jeffrey B. Newman exercised a stock grant, converting 20,000 derivative shares into 20,000 shares of common stock on August 04, 2026. The underlying grant for 20,000 shares was awarded on August 04, 2025 and fully vested by the filing date. Following the transaction he directly owned 90,000 shares of Paysign common stock.
Paysign, Inc. director Bruce A. Mina reported the vesting and conversion of a prior stock grant into 20,000 shares of common stock on August 04, 2026. The award was originally granted on August 04, 2025 and has now fully vested, bringing his directly held common stock to 278,500 shares.
Paysign, Inc. director Henry Daniel R reported exercising a stock grant covering 20,000 shares of common stock on August 4, 2026. The derivative Stock Grant for 20,000 underlying shares was converted into common stock at a reported price of $0.0000 per share, bringing his direct holdings to 169,884.498 common shares.
Paysign, Inc. CEO and 10% owner Mark Newcomer reported the vesting of restricted stock covering 150,000 shares on July 31, 2026, which converted into an equal number of common shares. In a related transaction, 59,025 shares were withheld by the issuer at $8.96 per share to satisfy tax withholding obligations. The restricted stock grant vests one-fifth each year from July 31, 2022 through July 31, 2027.
Paysign, Inc. Chief Legal Officer Robert Strobo reported the vesting and conversion of 64,000 shares of restricted stock into common stock on July 31, 2026. The award vests in five equal annual installments from July 31, 2022 to July 31, 2027. To cover tax obligations from this vesting, 25,184 shares of common stock were withheld by the issuer at $8.96 per share.
Paysign, Inc. EVP, EFT Operations Joan M. Herman reported equity compensation activity on July 31, 2026. A derivative "Stock Grant" tied to 36,000 restricted shares was exercised/vested into 36,000 shares of common stock at no cost, with 13,780 shares withheld at $8.96 per share to cover tax obligations under a grant that vests one-fifth annually from a July 31, 2022 commencement date.
Paysign, Inc. Chief Financial Officer Jeffery Bradford Baker exercised a stock grant covering 64,000 shares of common stock on July 31, 2026. The vesting comes from restricted stock that vests in equal annual installments through July 31, 2027, and 28,506 shares were withheld to satisfy related tax obligations at $8.96 per share.
Paysign, Inc. Chief Payments Officer Matthew Louis Lanford reported the vesting and exercise of 64,000 shares of restricted stock into common stock on July 31, 2026. Footnotes state this award vests in equal annual installments from July 31, 2022 through July 31, 2027. On the same date, 25,185 shares of common stock were withheld at $8.96 per share to satisfy associated tax withholding obligations.
Triplett Dennis L reported acquisition or exercise transactions in this Form 4 filing.
Paysign, Inc. director Dennis L. Triplett reported a compensation-related equity award. On May 8, 2026, he received a grant of 20,000 shares of Common Stock, with these shares scheduled to vest on May 8, 2027. Following this award, his directly held Common Stock position is 270,000 shares.
NEWMAN JEFFREY B reported acquisition or exercise transactions in this Form 4 filing.
Paysign, Inc. director Jeffrey B. Newman received a grant of 20,000 shares of common stock on May 8, 2026. These shares vest on May 8, 2027. Following the award, he directly holds 70,000 Paysign common shares.
Paysign, Inc. director Bruce A. Mina reported one equity award and two share sales. On May 8, 2026, Mina received a grant of 20,000 shares of common stock at $0.00 per share, scheduled to vest on May 8, 2027. He then sold 10,000 shares on June 1, 2026 at $7.10 per share and another 10,000 shares on June 11, 2026 at $7.095 per share in open market or private transactions. The filing’s Rule 10b5-1 checkbox is not marked as being under a trading plan.
HENRY DANIEL R reported acquisition or exercise transactions in this Form 4 filing.
Paysign, Inc. director and reporting person HENRY DANIEL R received a grant of 20,000 shares of common stock on May 8, 2026. These shares vest on May 8, 2027. Following the grant, he holds 149,884.198 shares of Paysign common stock in direct ownership.
Paysign, Inc. director, CEO and 10% owner Mark Newcomer reported selling 50,000 shares of Common Stock on July 29, 2026 at a weighted average price of $9.3797 per share, in trades ranging from $9.3720 to $9.39. The sale was effected under a Rule 10b5-1 trading plan adopted on September 12, 2025, leaving 9,222,027 shares held directly.
Paysign, Inc. EVP of Operations and director Joan M Herman reported open-market sales of a total of 59,904 shares of common stock on July 15–16, 2026, at weighted average prices of $8.5962 and $8.6932 per share. Following these transactions, Herman holds 647,105 shares directly. The sales were effected under a Rule 10b5-1 trading plan adopted on September 12, 2025.
Paysign, Inc. executive vice president of operations Joan M. Herman reported an open-market sale of 100,000 shares of common stock at a weighted average price of $8.0114 per share. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan adopted on September 12, 2025.
After this sale, Herman directly holds 707,009 shares of Paysign common stock. Because the sale occurred pursuant to a Rule 10b5-1 plan, it appears to be part of a scheduled diversification or liquidity program rather than a discretionary one-time trade.
Paysign, Inc. Chief Legal Officer Robert Strobo reported routine equity compensation activity and related tax withholding. On November 13, 2025, he acquired 200,000 shares of common stock as a performance-based restricted stock award, granted May 7, 2025 after an earnings target was achieved. This restricted stock vests in three equal installments on May 27, 2026, May 24, 2027, and May 26, 2028, contingent on his continued service. On May 27, 2026, 39,235 shares of common stock were withheld by Paysign to cover tax obligations tied to the vesting of this restricted stock. After these transactions, Strobo directly owned 488,055 shares of Paysign common stock.
Paysign, Inc.’s Chief Financial Officer Jeffery Bradford Baker reported equity compensation activity and related tax withholding in company stock. On November 13, 2025, he acquired 200,000 shares of common stock as a performance-based restricted stock award at $0.00 per share, following achievement of a specified earnings target. This award will vest in three equal installments on May 29, 2026, May 20, 2027, and May 30, 2028, subject to his continued service. On May 29, 2026, 44,541 shares of common stock were withheld by the issuer to cover tax obligations tied to the vesting of restricted stock, leaving him with 541,677 shares of common stock held directly after that transaction. The filing reflects routine compensation and tax-withholding events rather than open-market buying or selling.
Paysign, Inc. director and EVP of Operations Joan M. Herman reported an open-market sale of 22,534 shares of common stock at a weighted average price of $7.0133 per share on May 26, 2026. After this transaction, Herman directly holds 836,211 Paysign shares.
The sale was carried out under a pre-arranged Rule 10b5-1 trading plan, meaning the trades were scheduled in advance rather than timed discretionarily.
Paysign, Inc. CEO Mark Newcomer reported routine equity compensation activity. He received a grant of 400,000 shares of performance-based restricted stock on November 13, 2025, after an earnings target was achieved. As part of the vesting on May 20, 2026, 78,701 shares were withheld at $6.15 per share to cover tax obligations, leaving him with 9,272,027 common shares held directly.
Paysign, Inc. executive Joan M. Herman reported routine equity compensation activity and related tax withholding. On May 13, 2026, 6,171 shares of common stock were withheld at $5.83 per share to cover tax obligations from restricted stock vesting, leaving her with 858,745 directly held shares. Earlier, on November 13, 2025, she received a grant of 33,333 performance-based restricted shares at no cost, tied to an earnings target, scheduled to vest in thirds annually from 2026 through 2028, contingent on continued service.
Paysign, Inc. Chief Payments Officer Matthew Louis Lanford reported routine equity compensation activity. He received a grant of 66,666 shares of performance-based restricted stock, with the performance goal deemed satisfied on November 13, 2025 based on a specified earnings target.
The restricted stock is scheduled to vest in three equal installments on May 18, 2026, May 18, 2027, and May 18, 2028, subject to continued service. On May 18, 2026, 12,755 shares of common stock were withheld by Paysign to cover tax obligations tied to vesting, leaving Lanford with 234,609 shares held directly.
Paysign, Inc. executive Joan M. Herman, EVP of Operations and a director, sold 29,202 shares of common stock in an open-market transaction at a weighted average price of $8.0039 per share. The sale was executed under a pre-arranged Rule 10b5-1 trading plan, and Herman now holds 807,009 shares directly.
Paysign, Inc. Chief Legal Officer Robert Strobo reported compensation-related stock activity. On May 27, 2026, he received a grant of 66,667 shares of common stock at no cost, reflecting the vesting of performance-based restricted stock tied to specific earnings targets. On the same date, 39,235 shares of common stock were withheld by the company to cover tax obligations related to this vesting. Following these transactions, Strobo directly held 393,957 shares of Paysign common stock. The disposition was a tax-withholding mechanism rather than an open-market sale.
Paysign, Inc. executive Joan M. Herman, EVP of Operations and a director, reported an open-market sale of 22,534 shares of common stock at a weighted average price of $7.0133 per share on May 26, 2026. These shares were sold in multiple trades at prices ranging from $7.0001 to $7.0249 per share. After this transaction, Herman directly holds 813,989 shares of Paysign common stock. The sale was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on September 12, 2025, indicating the trades were scheduled in advance.
Paysign, Inc. CEO, director and 10% owner Mark Newcomer reported equity compensation activity dated May 20, 2026. He acquired 133,334 shares of common stock at no cost upon vesting of performance-based restricted stock tied to defined earnings targets, while 78,701 shares were withheld by the issuer to cover tax obligations. Following these transactions, he directly holds 9,005,361 Paysign common shares.
Paysign, Inc. Chief Payments Officer Matthew Louis Lanford reported routine equity compensation activity. On May 18, 2026, performance-based restricted stock vested based on defined earnings targets, resulting in a grant of 22,222 shares of common stock. To cover related tax obligations, 12,755 shares were withheld by the company at $5.865 per share. After these transactions, Lanford directly held 190,165 shares of Paysign common stock. These events reflect compensation vesting and tax withholding rather than open-market buying or selling.
Paysign, Inc. executive Joan M. Herman reported routine equity-compensation related transactions in company common stock. On May 13, 2026, performance-based restricted stock vested based on specific defined earnings targets, resulting in an award of 11,111 shares.
To cover associated tax withholding obligations from this vesting, 6,171 shares were withheld by the issuer at a reference price of $5.83 per share. These are not open-market sales or purchases, but mechanical entries tied to compensation. After these transactions, Herman directly holds 836,523 shares of Paysign common stock.
Paysign, Inc. executive Joan M. Herman, EVP of Operations and a director, sold 6,667 shares of common stock in an open-market transaction on May 4, 2026 at a weighted average price of $7.0102 per share.
The transaction was effected under a pre-arranged Rule 10b5-1 trading plan adopted on September 12, 2025, indicating it was scheduled in advance. Following this sale, Herman directly holds 831,583 shares of Paysign common stock.
Paysign, Inc. Chief Financial Officer Jeffery Bradford Baker exercised a derivative award for 60,000 shares on February 28, 2026, receiving 60,000 shares of common stock at a stated price of $0.00 per share. A separate transaction shows 26,055 common shares withheld at $3.55 per share to cover tax obligations linked to the vesting of restricted stock units. After these transactions, Baker directly owned 386,218 shares of Paysign common stock. Footnotes indicate the restricted stock vested in five equal annual installments beginning February 28, 2021 and completing on February 28, 2026.